Initial detection of circulating tumor cells from metastatic prostate cancer patients with a novel small device

de Bono, 2008, Phase I pharmacokinetic and pharmacodynamic study of LAQ824, a hydroxamate histone deacetylase inhibitor with a heat shock protein-90 inhibitory profile, in patients with advanced solid tumors, Clin Cancer Res, 14, 6663, 10.1158/1078-0432.CCR-08-0376 Scher, 2009, Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data, Lancet Oncol, 10, 233, 10.1016/S1470-2045(08)70340-1 Goldkorn, 2014, Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer, J Clin Oncol, 32, 1136, 10.1200/JCO.2013.51.7417 Fleisher, 2015, Circulating tumor cell (CTC) enumeration in men with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide post-chemotherapy (phase 3 AFFIRM study), J Clin Oncol, 33, 5035, 10.1200/jco.2015.33.15_suppl.5035 Scher, 2015, Circulating tumor cell biomarker panel as an individual-level surrogate for survival in metastatic castration-resistant prostate cancer, J Clin Oncol, 33, 1348, 10.1200/JCO.2014.55.3487 Lorente, 2016, Decline in circulating tumor cell count and treatment outcome in advanced prostate cancer, Eur Urol, 70, 985, 10.1016/j.eururo.2016.05.023 Joosse, 2015, Biology, detection, and clinical implications of circulating tumor cells, EMBO Mol Med, 7, 1, 10.15252/emmm.201303698 Nagrath, 2007, Isolation of rare circulating tumour cells in cancer patients by microchip technology, Nature, 450, 1235, 10.1038/nature06385 Maheswaran, 2008, Detection of mutations in EGFR in circulating lung-cancer cells, N Engl J Med, 359, 366, 10.1056/NEJMoa0800668 Ohnaga, 2013, Polymeric microfluidic devices exhibiting sufficient capture of cancer cell line for isolation of circulating tumor cells, Biomed Microdevices, 15, 611, 10.1007/s10544-013-9775-7 Chikashi, 2017, EpCAM-independent capture of circulating tumor cells with a ‘universal CTC-chip’, Oncol Rep, 37, 77, 10.3892/or.2016.5235 Riethdorf, 2007, Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system, Clin Cancer Res, 13, 920, 10.1158/1078-0432.CCR-06-1695 Moreno, 2005, Circulating tumor cells predict survival in patients with metastatic prostate cancer, Urol Times, 65, 713, 10.1016/j.urology.2004.11.006 Danila, 2007, Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer, Clin Cancer Res, 13, 7053, 10.1158/1078-0432.CCR-07-1506 Ide, 2014, Circulating tumor cell count during zoledronic acid treatment in men with metastatic prostate cancer: a pilot study, Prostate Int, 2, 147, 10.12954/PI.14056 de Bono, 2008, Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer, Clin Cancer Res, 14, 6302, 10.1158/1078-0432.CCR-08-0872 Beltran, 2016, The initial detection and partial characterization of circulating tumor cells in neuroendocrine prostate cancer, Clin Cancer Res, 22, 1510, 10.1158/1078-0432.CCR-15-0137 Kagan, 2002, A sample preparation and analysis system for identification of circulating tumor cells, J Clin Ligand Assay, 25, 104 Gradilone, 2011, Circulating tumor cells and “suspicious objects” evaluated through CellSearch® in metastatic renal cell carcinoma, Anticancer Res, 31, 4219 Zhang, 2017, The prognostic and diagnostic value of circulating tumor cells in bladder cancer and upper tract urothelial carcinoma: a meta-analysis of 30 published studies, Oncotarget, 8, 59527, 10.18632/oncotarget.18521 Nastaly, 2014, Circulating tumor cells in patients with testicular germ cell tumors, Clin Cancer Res, 20, 3830, 10.1158/1078-0432.CCR-13-2819 Okegawa, 2008, Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer, J Urol, 180, 1342 Park, 2014, Morphological differences between circulating tumor cells from prostate cancer patients and cultured prostate cancer cells, PLoS One, 9, e85264, 10.1371/journal.pone.0085264 Iwatsuki, 2009, Epithelial–mesenchymal transition in cancer development and its clinical significance, Cancer Sci, 101, 293, 10.1111/j.1349-7006.2009.01419.x Gorges, 2012, Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition, BMC Cancer, 12, 178, 10.1186/1471-2407-12-178 Pecot, 2011, A novel platform for detection of CK+ and CK− CTCs, Cancer Discov, 1, 580, 10.1158/2159-8290.CD-11-0215 Ohnaga, 2018, Highly efficient capture of cancer cells expressing EGFR by microfluidic methods based on antigen-antibody association, Sci Rep, 8, 12005, 10.1038/s41598-018-30511-9